SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-18-017590
Filing Date
2018-01-23
Accepted
2018-01-23 17:12:05
Documents
7
Group Members
BLINK ACQUISITION CORP.SANOFI-AVENTIS AMERIQUE DU NORD SASSANOFI-AVENTIS NA HOLDING, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C d515941dsctoc.htm SC TO-C 14923
2 EX-99.1 d515941dex991.htm EX-99.1 54400
3 GRAPHIC g515941g02t30.jpg GRAPHIC 2139
4 GRAPHIC g515941g31k18.jpg GRAPHIC 3899
5 GRAPHIC g515941g31o08.jpg GRAPHIC 2560
6 GRAPHIC g515941g73c96.jpg GRAPHIC 3558
7 GRAPHIC g515941g87l50.jpg GRAPHIC 2595
  Complete submission text file 0001193125-18-017590.txt   92135
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 225 2ND AVENUE WALTHAM MA 02451
Business Address 225 2ND AVENUE WALTHAM MA 02451 781-663-4400
Bioverativ Inc. (Subject) CIK: 0001681689 (see all company filings)

IRS No.: 813461310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-89883 | Film No.: 18543340
SIC: 2834 Pharmaceutical Preparations